The Drug Enforcement Administration announced Wednesday it’s making research into the non-intoxicating cannabis compound cannabidiol (CBD) easier, but advocates for legal access to what appears an effective treatment for epilepsy say the change doesn’t go nearly far enough.
WeedLife News Network
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.
Christmas came early for cannabis research scientists. The U.S. Drug Enforcement Agency (DEA) decided to ease some of the regulatory requirements that had been imposed on those who were conducting FDA-approved clinical trials on cannabidiol (CBD).
The Drug Enforcement Administration is not having a great year.
The chief of the agency stepped down in April under a cloud of scandal.
DEA chief Chuck Rosenberg on Wednesday rejected the notion that smoking marijuana is "medicine," calling the premise a "joke."
Steven Nelson ~ U.S. News & World Report ~
Authorities claim the plants were marijuana, not hemp – but evidence is lacking.